Nutex Health Inc.
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
NUTX$194.16+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (In thousands, except share and per share amounts) | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $185,574 | $40,640 |
| Restricted cash | 297 | — |
| Restricted short-term investments | — | 2,941 |
| Accounts receivable | 319,440 | 232,449 |
| Accounts receivable - related parties | 5,978 | 3,602 |
| Inventories | 2,866 | 2,850 |
| Prepaid expenses and other current assets | 24,656 | 9,997 |
| Total current assets | 538,811 | 292,479 |
| Property and equipment, net (accumulated depreciation of 31,696 and 25,271 as December 31, 2025 and December 31, 2024, respectively) | 94,581 | 77,933 |
| Operating lease right-of-use assets | 26,955 | 27,872 |
| Financing lease right-of-use assets | 222,367 | 218,889 |
| Intangible assets, net | 21,230 | 15,530 |
| Goodwill, net | 13,919 | 13,919 |
| Deferred tax assets | — | 7,987 |
| Other assets | 662 | 711 |
| Total assets | $918,525 | $655,320 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Accounts payable | $45,863 | $9,614 |
| Accounts payable - related parties | 3,104 | 806 |
| Lines of credit | 740 | 3,554 |
| Current portion of long-term debt | 13,336 | 14,395 |
| Operating lease liabilities, current portion | 2,152 | 2,080 |
| Financing lease liabilities, current portion | 7,077 | 7,705 |
| Accrued arbitration expenses | 49,743 | 47,742 |
| Accrued income tax expense | 867 | 26,533 |
| Accrued stock-based compensation | 8,256 | 16,356 |
| Accrued expenses and other current liabilities | 26,773 | 25,440 |
| Total current liabilities | 157,911 | 154,225 |
| Long-term debt, net | 29,174 | 22,466 |
| Non-current operating lease liabilities, net | 30,037 | 30,617 |
| Non-current financing lease liabilities, net | 268,877 | 259,479 |
| Deferred tax liabilities | 9,089 | — |
| Total liabilities | 495,088 | 466,787 |
| Commitments and contingencies (Note 10) | ||
| Equity: | ||
| Common stock, $0.001 par value; 950,000,000 shares authorized; 7,086,670 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 7 | 6 |
| Additional paid-in capital | 615,627 | 489,409 |
| Accumulated deficit | (286,187) | (356,976) |
| Nutex Health Inc. equity | 329,447 | 132,439 |
| Noncontrolling interests | 93,990 | 56,094 |
| Total equity | 423,437 | 188,533 |
| Total liabilities and equity | $918,525 | $655,320 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.